Related references
Note: Only part of the references are listed.Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer
Tibor Szarvas et al.
BJU INTERNATIONAL (2021)
Voltage-Gated Calcium Channels in Nonexcitable Tissues
Geoffrey S. Pitt et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 83 (2021)
Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
Mauro Scaravilli et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Calcium and cell function
Murali Prakriya et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells
Belen G. Sanchez et al.
CELLS (2020)
Store-Operated Ca2+ Entry in Tumor Progression: From Molecular Mechanisms to Clinical Implications
Yih-Fung Chen et al.
CANCERS (2019)
Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
Qin Feng et al.
FRONTIERS IN ONCOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
Heather Nesbitt et al.
CLINICAL CANCER RESEARCH (2017)
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
David T. Hoang et al.
ONCOTARGET (2017)
Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
Pan Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Mechanisms of Therapeutic Resistance in Prostate Cancer
Mary Nakazawa et al.
CURRENT ONCOLOGY REPORTS (2017)
Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity
Yann Fourbon et al.
SCIENTIFIC REPORTS (2017)
Store-operated calcium entry is dispensable for the activation of ERK1/2 pathway in prostate cancer cells
Aida M. Lopez-Guerrero et al.
CELLULAR SIGNALLING (2017)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Xiaoju Wang et al.
CANCER CELL (2017)
Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer
Tsogt-Ochir Dondoo et al.
ANTICANCER RESEARCH (2017)
L-type Cav1.3 channels regulate ryanodine receptor-dependent Ca2+ release during sino-atrial node pacemaker activity
Angelo Giovanni Torrente et al.
CARDIOVASCULAR RESEARCH (2016)
Endocrine Response Phenotypes Are Altered by Charcoal-Stripped Serum Variability
Matthew J. Sikora et al.
ENDOCRINOLOGY (2016)
CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics
Paul J. Buchanan et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2016)
Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30
Yanlei Ji et al.
ONCOLOGY REPORTS (2016)
Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration
Nadine Deliot et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Arndt Katzenwadel et al.
CANCER LETTERS (2015)
Endoplasmic reticulum Ca2+ content decrease by PKA-dependent hyperphosphorylation of type 1 IP3 receptor contributes to prostate cancer cell resistance to androgen deprivation
Benoit Boutin et al.
CELL CALCIUM (2015)
Ca2+ channel subunit α 1D promotes proliferation and migration of endometrial cancer cells mediated by 17β-estradiol via the G protein-coupled estrogen receptor
Juan Hao et al.
FASEB JOURNAL (2015)
No evidence for increased prostate cancer risk among calcium channel blockers user
Yu Fan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
STORE-OPERATED CALCIUM CHANNELS
Murali Prakriya et al.
PHYSIOLOGICAL REVIEWS (2015)
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
Milan S. Geybels et al.
CLINICAL EPIGENETICS (2015)
Guidelines for the use of cell lines in biomedical research
R. J. Geraghty et al.
BRITISH JOURNAL OF CANCER (2014)
Remodeling of Channel-Forming ORAI Proteins Determines an Oncogenic Switch in Prostate Cancer
Charlotte Dubois et al.
CANCER CELL (2014)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer
Joost L. Boormans et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The voltage-dependent L-type Ca2+ (CaV1.2) channel C-terminus fragment is a bi-modal vasodilator
John P. Bannister et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
Dominick G. A. Burton et al.
PLOS ONE (2013)
C-Terminal Alternative Splicing of CaV1.3 Channels Distinctively Modulates Their Dihydropyridine Sensitivity
Hua Huang et al.
MOLECULAR PHARMACOLOGY (2013)
Molecular Subtyping of Primary Prostate Cancer Reveals Specific and Shared Target Genes of Different ETS Rearrangements
Paula Paulo et al.
NEOPLASIA (2012)
New therapies for castrate-resistant prostate cancer
Stephen B. Williams et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting
Annalisa Zuccotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
ATCC technology assessment of Roche xCELLigence System: an electronic impedance-based cell sensing unit
Kurt Langenbach
BIOTECHNIQUES (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells
M. Flourakis et al.
CELL DEATH & DISEASE (2010)
Insights into Ca2+ homeostasis of advanced prostate cancer cells
Matthieu Flourakis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Functional interaction of neuronal cav1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus
Sunoh Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ion channels in death and differentiation of prostate cancer cells
N. Prevarskaya et al.
CELL DEATH AND DIFFERENTIATION (2007)
The C terminus of the L-type voltage-gated calcium channel Cav1.2 encodes a transcription factor
Natalia Gomez-Ospina et al.
CELL (2006)
The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide
A Hobisch et al.
PROSTATE (2006)
Intracellular calcium store filling by an L-type calcium current in the basolateral amygdala at subthreshold membrane potentials
JM Power et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
K Vanoverberghe et al.
CELL DEATH AND DIFFERENTIATION (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Overexpression of an α1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells
P Mariot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells:: involvement in apoptosis
R Skryma et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Share Paper
